OBJECTIVE: To explore the left ventricular (LV) electrical activation pattern in heart failure (HF) and its implication to cardiac resynchronization therapy (CRT). DESIGN AND SETTING: Observational study at the University Teaching Hospital. PATIENTS: 23 optimally treated patients with HF with New York Heart Association class III, QRS duration >120 ms and LV ejection fraction <35%. INTERVENTIONS: The LV endocardial activation pattern and total activation time (Tat) was determined by non-contact mapping and the LV mechanical dys-synchrony was determined by standard deviation (Ts-SD) and maximal difference (Ts-diff) of time to peak systolic contraction (Ts) among 12 LV segments using tissue Doppler imaging before receiving CRT. MAIN OUTCOME MEASURES: Correlation between electrical and mechanical dys-synchrony; volumetric responder to CRT at 3 months; HF hospitalisation or death by Kaplan-Meier analysis. RESULTS: Homogenous (type I, n = 8) and presence of conduction block (type II, n = 15) patterns were identified. Significant correlation between Tat and Ts-SD/Ts-diff was noted only in type II (r = 0.73/0.56, p = 0.002/0.03). Ts-SD and Ts-diff in type II were significantly longer than type I. 12 patients in type II and 2 in type I were CRT responders (p = 0.01). After 487 (447) days, patients with type II pattern had significantly lower risk of HF hospitalisation or death than those with type I (log rank chi(2) = 5.25; p = 0.02). CONCLUSION: Patients with type II LV endocardial activation pattern had a more favourable echocardiographic and clinical response to CRT than those with type I pattern.
OBJECTIVE: To explore the left ventricular (LV) electrical activation pattern in heart failure (HF) and its implication to cardiac resynchronization therapy (CRT). DESIGN AND SETTING: Observational study at the University Teaching Hospital. PATIENTS: 23 optimally treated patients with HF with New York Heart Association class III, QRS duration >120 ms and LV ejection fraction <35%. INTERVENTIONS: The LV endocardial activation pattern and total activation time (Tat) was determined by non-contact mapping and the LV mechanical dys-synchrony was determined by standard deviation (Ts-SD) and maximal difference (Ts-diff) of time to peak systolic contraction (Ts) among 12 LV segments using tissue Doppler imaging before receiving CRT. MAIN OUTCOME MEASURES: Correlation between electrical and mechanical dys-synchrony; volumetric responder to CRT at 3 months; HF hospitalisation or death by Kaplan-Meier analysis. RESULTS: Homogenous (type I, n = 8) and presence of conduction block (type II, n = 15) patterns were identified. Significant correlation between Tat and Ts-SD/Ts-diff was noted only in type II (r = 0.73/0.56, p = 0.002/0.03). Ts-SD and Ts-diff in type II were significantly longer than type I. 12 patients in type II and 2 in type I were CRT responders (p = 0.01). After 487 (447) days, patients with type II pattern had significantly lower risk of HF hospitalisation or death than those with type I (log rank chi(2) = 5.25; p = 0.02). CONCLUSION:Patients with type II LV endocardial activation pattern had a more favourable echocardiographic and clinical response to CRT than those with type I pattern.
Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Cheuk-Man Yu; Jeffrey Wing-Hong Fung; Qing Zhang; Chi-Kin Chan; Yat-Sun Chan; Hong Lin; Leo C C Kum; Shun-Ling Kong; Yan Zhang; John E Sanderson Journal: Circulation Date: 2004-06-14 Impact factor: 29.690
Authors: Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245
Authors: Jeroen J Bax; Theodore Abraham; S Serge Barold; Ole A Breithardt; Jeffrey W H Fung; Stephane Garrigue; John Gorcsan; David L Hayes; David A Kass; Juhani Knuuti; Christophe Leclercq; Cecilia Linde; Daniel B Mark; Mark J Monaghan; Petros Nihoyannopoulos; Martin J Schalij; Christophe Stellbrink; Cheuk-Man Yu Journal: J Am Coll Cardiol Date: 2005-12-20 Impact factor: 24.094
Authors: Cheuk-Man Yu; Elaine Chau; John E Sanderson; Katherine Fan; Man-Oi Tang; Wing-Hong Fung; Hong Lin; Shun-Ling Kong; Yui-Ming Lam; Michael R S Hill; Chu-Pak Lau Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Cheuk-Man Yu; Gabe B Bleeker; Jeffrey Wing-Hong Fung; Martin J Schalij; Qing Zhang; Ernst E van der Wall; Yat-Sun Chan; Shun-Ling Kong; Jeroen J Bax Journal: Circulation Date: 2005-09-06 Impact factor: 29.690
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Gregory R Hartlage; Jonathan D Suever; Stephanie Clement-Guinaudeau; Patrick T Strickland; Nima Ghasemzadeh; R Patrick Magrath; Ankit Parikh; Stamatios Lerakis; Michael H Hoskins; Angel R Leon; Michael S Lloyd; John N Oshinski Journal: J Cardiovasc Magn Reson Date: 2015-07-14 Impact factor: 5.364
Authors: Elien B Engels; Masih Mafi-Rad; Antonius M W van Stipdonk; Kevin Vernooy; Frits W Prinzen Journal: J Cardiovasc Transl Res Date: 2016-05-26 Impact factor: 4.132
Authors: Andrew Crozier; Bojan Blazevic; Pablo Lamata; Gernot Plank; Matthew Ginks; Simon Duckett; Manav Sohal; Anoop Shetty; Christopher A Rinaldi; Reza Razavi; Nicolas P Smith; Steven A Niederer Journal: J Mol Cell Cardiol Date: 2015-11-04 Impact factor: 5.000